Recombinant Human Interleukin-1 Receptor Antagonist (Zhejiang Hisun Pharmaceutical)

N/A

Report date: 2025/01/26 16:57:30

Base Information

Drug NameRecombinant Human Interleukin-1 Receptor Antagonist (Zhejiang Hisun Pharmaceutical)
Drug Alias NamerhIL-1ra (Zhejiang Hisun Pharmaceutical)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesZhejiang Hisun Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Hisun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A